Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
300 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 298 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
362 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-06-19 | 2023-06-27 | 195637 |
TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2023-07-11 | 2023-12-14 | 198280 |
TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2023-07-11 | 2023-12-14 | 198283 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-07-18 | 2023-10-06 | 199015 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-07-27 | 2023-10-06 | 200223 |
TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2023-07-27 | 2023-12-14 | 200226 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-11-03 | 2023-12-14 | 209139 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-11-03 | 2023-12-14 | 209142 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-08-27 | 2021-10-14 | 144769 |
TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-11-25 | 2021-12-23 | 149945 |
TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-12-17 | 2021-12-23 | 151471 |
TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-02-24 | 2022-03-09 | 155554 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2024-08-08 | 2025-01-09 | 234870 |
TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Actual shortage | 2024-07-11 | 2025-05-08 | 232735 |
TEVA-TRIACOMB | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2020-02-21 | 2020-04-02 | 106934 |
TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2024-10-11 | 2025-01-09 | 240075 |
TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2021-03-04 | 2021-11-18 | 135132 |
TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2021-04-15 | 2021-11-18 | 137538 |
TEVA-TRIACOMB | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-12-19 | 2020-04-02 | 101722 |
TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2022-01-20 | 2023-07-14 | 153153 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |
TEVA-PRAVASTATIN | 40MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253177 |
TEVA-PRAVASTATIN | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253174 |
TEVA-PRAVASTATIN | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253171 |
TEVA-PREDNISONE | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81376 |
TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
TEVA-PROCTOSONE | 1% 1% 0.5% 0.5% | OINTMENT | Discontinued | 2025-04-25 | 2025-04-25 | 255840 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120015 |
TEVA-RABEPRAZOLE EC | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120018 |
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 |